Glycogen storage disease type I: pathophysiology of liver adenomas.
about
Glucose-6-phosphatase deficiencyNatural history of hepatocellular adenoma formation in glycogen storage disease type ILiver tumors in children with metabolic disordersMolecular pathogenesis of hepatic adenomas and its implications for surgical managementGlycogen storage disease type I and G6Pase-β deficiency: etiology and therapyDevelopment of hepatocellular adenomas and carcinomas in mice with liver-specific G6Pase-α deficiencyInsights into the pathogenesis and treatment of cancer from inborn errors of metabolism.Giant hepatic adenoma with bone marrow metaplasia not associated with oral contraceptive intake.Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I.The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenomaA Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer.SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.Perioperative management of hemostasis for surgery of benign hepatic adenomas in patients with glycogen storage disease type ia.Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage diseaseGlycogen Storage Disease type 1a - a secondary cause for hyperlipidemia: report of five cases.Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk/benefit of this procedure.Successful treatment of multiple hepatocellular adenomas with percutaneous radiofrequency ablation.Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia.Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: A case report.Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control.Stereotactic radiofrequency ablation for liver tumors in inherited metabolic disorders.Multiple hepatic adenomas in a child with microvillus inclusion disease.Contrast-enhanced ultrasonography in patients with glycogen storage disease type Ia and adenomas.Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia.Hepatocyte transplantation for glycogen storage disease type Ib.Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular study.
P2860
Q21202870-618EDF7A-43C2-4352-8F61-2692BBC9A0A9Q24633522-910121BE-B374-4A29-BC4A-7CDEF7031073Q26770292-8DC57173-379E-4365-A887-087818F3AEF7Q27027370-EDDCF443-6602-4ADB-A78F-4F55D5E1F492Q28296663-83F711C8-FB38-4071-87E2-9D250EA37CC2Q34081768-E62CEFF4-F3E0-483F-9C5E-92DAAFBF18A8Q34768395-5AF5824D-D464-4290-A74C-B9CAB72C3A06Q35017392-1DE34BD4-9C43-4AB1-9C90-D6D4CF86DD57Q35183122-D1FA8691-7E75-46D5-BFB2-B7BD23827509Q35479152-0E4A9CAC-A951-44E5-9658-F14C11131380Q35650424-00CAAEDB-C9EA-4D10-881D-ABA230541B08Q35991536-4FF3434F-4209-40FB-9B55-C2334659CFFEQ36300613-47660841-74D0-439A-A925-8F47D10B6B5CQ36433240-9E9EF5CD-160D-4CB2-A3DA-ABB60871039AQ36777763-BFFE01A5-AC68-46D5-88C6-71652C9116FBQ36944402-3CD7845C-A1F8-4DE0-8FA9-C157EA5E4A5AQ37097027-1E3B28F7-ACD8-4301-BB3D-2DC0D5C7B1D4Q37317507-50ACF0F4-ABEB-4B06-959E-456747DADE5AQ37348313-BF749409-2309-4CAC-A4E7-CA26E39BEBA9Q37387718-66ACFA02-93C9-4737-A936-84D6BFC7AAC9Q37406790-6039FF7A-006E-4A87-B5F1-8141545EAB3CQ38263927-9AAFD1A0-4DF1-453B-93C4-1B73BF978B4AQ39343139-0FA87E91-5167-4289-95FA-D1DD38001D0AQ45183031-4A69F945-7BD9-43C1-AC5E-097AF4A62CC0Q45805217-89004979-FA43-4EF3-AE92-C486ECBA5BFAQ46195729-A9C47177-1F8F-4050-8582-ED3B35EC6D5EQ46661401-F40A343F-A3A6-453D-9523-BE72AEC1EC35Q46969458-50D1CC79-5240-434B-A648-9C8AC96C4135Q47734094-544D014F-490E-40D0-A703-841FB9ADD044Q53654697-88C73144-E83D-49CC-B812-4BB6A1866C27
P2860
Glycogen storage disease type I: pathophysiology of liver adenomas.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Glycogen storage disease type I: pathophysiology of liver adenomas.
@ast
Glycogen storage disease type I: pathophysiology of liver adenomas.
@en
Glycogen storage disease type I: pathophysiology of liver adenomas.
@nl
type
label
Glycogen storage disease type I: pathophysiology of liver adenomas.
@ast
Glycogen storage disease type I: pathophysiology of liver adenomas.
@en
Glycogen storage disease type I: pathophysiology of liver adenomas.
@nl
prefLabel
Glycogen storage disease type I: pathophysiology of liver adenomas.
@ast
Glycogen storage disease type I: pathophysiology of liver adenomas.
@en
Glycogen storage disease type I: pathophysiology of liver adenomas.
@nl
P2860
P356
P1476
Glycogen storage disease type I: pathophysiology of liver adenomas.
@en
P2093
Philip J Lee
P2860
P2888
P356
10.1007/BF02679993
P478
161 Suppl 1
P577
2002-07-12T00:00:00Z
P6179
1037785485